Activation of the renin-angiotensin system during cardiopulmonary bypass (CPB) may be involved in early postoperative hypertension after coronary artery bypass grafting (CABG). As hypertensive episodes may be deleterious in the immediate postoperative period, we have assessed the effects of prophylactic treatment with the angiotensin-converting enzyme inhibitor quinaprilat in an open study. During steady state CPB, patients received quinaprilat 0.02 mg kg -1 (group A, nϭ10), quinaprilat 0.04 mg kg -1 (group B, nϭ10) or saline solution (group C, nϭ 10) as an i.v. bolus dose. Sodium nitroprusside (SNP) was given after operation when systolic arterial pressure was Ͼ150 mm Hg. Requirements for SNP 1 h after arrival in the ICU were significantly less in groups A (two of 10) and B (two of 10) than in group C (eight of 10). Also, patients in group C had a greater systolic arterial pressure compared with groups A and B. There were no significant differences between groups in diastolic arterial pressure, heart rate, cardiac index or cardiac filling pressures. We conclude that quinaprilat can be used during CABG to reduce the incidence of postoperative hypertension. Further studies of the efficacy and safety of this technique are necessary.
Postoperative hypertension is a common problem in patients Methods and results undergoing coronary artery bypass grafting (CABG) . 1 The After obtaining approval from the Local Ethics Committee consequences of perioperative hypertension may be deleteri-and informed consent, we studied 30 patients undergoing ous and include an increase in myocardial workload and elective CABG. Patients with pre-existing cardiac failure myocardial oxygen consumption in addition to bleeding (ejection fraction Ͻ50%, as estimated by ventriculography), from vascular suture lines and cerebrovascular haemorrhage. renal insufficiency (serum creatinine Ͼ2.0 mmol litre -1 ) or It has been shown that an increase in systemic vascular impaired liver function (GOT Ͼ30 u. litre -1 , GPT resistance is a major determinant of increased arterial Ͼ30 u. litre -1 ), and those receiving ACE inhibitors or who pressure. In addition to neurogenic reflexes, humoral factors suffered previous unacceptable side effects from ACE such as epinephrine, norepinephrine, renin and angiotensin inhibitors were excluded. Using a randomized sequence, have been implicated in the pathophysiology of vasoconpatients were allocated prospectively to group A (quinaprilat striction. 2 Little information is available on the prophylactic 0.02 mg kg -1 , nϭ10), group B (quinaprilat 0.04 mg kg -1 , use of angiotensin-converting enzyme (ACE) inhibitors to nϭ10) or group C (control, nϭ10). Preoperative drug prevent hypertension after cardiac surgery. treatment included nitrates (group A, nϭ8; group B, nϭ9; Quinaprilat is the active metabolite of the non-sulphydryl group C, nϭ8), beta-adrenergic blocking drugs (group A, ACE inhibitor quinapril. Its onset time after i.v. administranϭ6; group B, nϭ6; group C, nϭ7) and calcium channel tion is within 15 min and its duration of action is at least blockers (group A, nϭ3; group B, nϭ4; group C, nϭ3). 12 h. 3 No data are available on the effects of quinaprilat as These were continued until the day of surgery. prophylactic treatment of postoperative hypertension. The
On the morning of surgery, patients received flunitraaim of this open study was to evaluate the effects of zepam 2 mg and morphine 30 mg for oral premedication, intraoperative pretreatment with quinaprilat i.v. on the incidence of hypertension after cardiac surgery.
approximately 1 h before anaesthesia. Anaesthesia was Effect of quinaprilat on hypertension after coronary artery surgery CPB were used. In all patients, rewarming began using the PCWP (mm Hg) integral heat exchanger of the oxygenator and a warming Group A 11 (4) 11 (3) 10 (4) 13 (4) mattress when the final distal anastomosis was started.
Group B 11 (5) 9 (3) 11 (7) 13 (3) Group C 10 (4) 9 (6) 9 (3) 11 (5) Rewarming was adjusted to reach 37°C before weaning from CPB was started. After CPB, blood remaining in the extracorporeal circuit was salvaged using a haemofiltration For statistical analysis, the SPSS 7.5 for Windows 95 technique and autologous blood was retransfused. The NT computer package was used. For a power of 80%, 10 therapeutic management of patients during anaesthesia and patients in each group were required to demonstrate 50% in the ICU followed the standard procedures of our institu-reduction in the incidence of postoperative hypertension. tion and was performed by physicians who were not Data are expressed as mean (SD). Baseline data (T0) and involved in the study. Postoperative systolic arterial pressure consecutive data (T1, T2, T3) for each group of patients (SAP) greater than 150 mm Hg for more than 5 min, were compared using the t test for dependent samples. despite adequate analgesia and sedation in the intubated To determine differences between groups, the t test for and normoventilated patient, was defined as an indication independent samples was used. For categorical data, Fisher's for sodium nitroprusside (SNP).
exact test was used. PϽ0.05 was considered significant. Haemodynamic variables, including cardiac output measPatient characteristics and details of the surgical procedured by thermodilution (mean of three measurements), ures did not differ between groups. Haemodynamic data were recorded. The need for inotropic, vasoconstrictor or are presented in Table 1 . In all three groups, SAP and vasodilator drugs after operation was noted. Baseline values diastolic arterial pressure (DAP) were significantly higher were measured during steady state anaesthesia before sur-at T3 compared with baseline. However, SAP at T3 was gery (T0). During steady state CPB (approximately 20 min significantly lower in both groups who received quinaprilat after the start of CPB, after haemoconcentration and stabil-compared with controls. At T3, eight patients in the control ization of temperature), quinaprilat (groups A and B) or group required infusion of SNP to compensate for acute saline solution (group C) was given as an i.v. bolus. postoperative hypertension compared with two patients in Measurements were repeated 5 min after weaning off CPB group A and two in group B. There was no difference (T1), at the end of surgery (T2) and 60 min after arrival in between groups in heart rate, cardiac index, central venous the ICU (T3). During CPB, norepinephrine was given to pressure or pulmonary capillary wedge pressure. No patient maintain mean arterial pressure (MAP) Ͼ50 mm Hg. received inotropics or vasoconstrictors during or after weanWhen MAP was Ͼ100 mm Hg, sufentanil 0.2 µg kg -1 and ing from CPB. midazolam 0.1 mg kg -1 were given followed by a vasodilator when necessary. All patients who received norepinephrine Comment (nϭ0) after application of the test drugs or those that required another vasodilator (group B, nϭ1; group C, nϭ Although plasma angiotensin II concentrations were not measured in this study, it has been shown previously that 1) were excluded. activation of the renin-angiotensin system with increased and quinaprilat groups. The only difference was the introduction of quinaprilat. Our data suggest that quinaprilat concentrations of angiotensin II occurs during CPB and may be involved in hypertension after coronary bypass. 2 can be used during CABG to reduce the incidence of postoperative hypertension. Further studies are necessary Our data may indicate that block of the renin-angiotensin system with quinaprilat during coronary artery bypass to confirm these results and to comment on the safety of this technique. surgery can be used to prevent postoperative hypertension. In contrast with our findings, Colson and colleagues reported that preoperative block of the renin-angiotensin system References using an oral ACE inhibitor failed to prevent hypertension 1 Leslie JB. Incidence and aetiology of perioperative hypertension.
after coronary artery surgery. 4 However, this group used Acta Anaesthesiol Scand Suppl. 1993; 99: 5-9 captopril, an ACE inhibitor with a lower inhibitory potency 2 Taylor KM, Bain WH, Morton JJ. The role of angiotensin II in the and a shorter half-life than quinaprilat. Boldt and colleagues development of peripheral vasoconstriction during open-heart surgery. Am Heart J 1980; 100: reported that i.v. administration of the ACE inhibitor concerning postoperative haemodynamics were presented.
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We found no difference between the intervention and control Management of patients was consistent between the control
